GINA 2006: asthma control as the main goal of treatment and criterion of efficacy of the therapy

1. Архипов В.В., Цой А.Н. GINA 2006: новые рекомендации по фармакотерапии бронхиальной астмы. Рус. мед. журн. 2007; 15 (4): 255–259.

2. Чучалин А.Г. (ред.). Глобальная стратегия лечения и профилактики бронхиальной астмы (пересмотр 2006 г.). М.: Атмосфера; 2007.

3. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2004. [ www.ginasthma.org; accessed January 09 2007].

4. National Institutes of Health. National Asthma Education and Prevention Program. Guidelines for the diagnosis and management of asthma: expert panel report 2. Publ. 97–4051. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute; 1997.

5. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. 2005. [www.ginasthma.org; accessed January 09 2007].

6. Barnes N.C., Williams A.E. Unscheduled healthcare resource use among asthma patients receiving low-dose inhaled corticosteroids maintenance treatment. Int. J. Clin. Pract. 2005; 59 (9): 1017–1024.

7. Chapman K.R. Impact of 'mild' asthma on health outcomes: findings of a systematic search of the literature. Respir. Med. 2005; 99 (11): 1350–1362.

8. Zeiger R.S., Bird S.R., Kaplan M.S. et al. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial. Am. J. Med. 2005; 118 (6): 649–657.

9. Bateman E.D., Boushey H.A., Bousquet J. et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am. J. Respir. Crit. Care Med. 2004; 170 (8): 836–844.

10. Огородова Л.М. Исследование GOAL (достижение оптимального контроля астмы). Новая цель терапии астмы. Мед. новости: науч.-практ. информ.-аналит. журн. для врачей и руководителей здравоохр. 2005; 4: 44–49.

11. Bateman E.D., Bousquet J., Keech M.L. et al. The correlation between asthma control and health status: the GOAL study. Eur. Respir. J. 2007; 29 (1): 56–62.

12. Nathan R.A., Sorkness C.A., Kosinski M. et al. Development of the asthma control test: a survey for assessing asthma control. J. Allergy Clin. Immunol. 2004; 113 (1): 59–65.

13. Juniper E.F., O'Byrne P.M., Guyatt G.H. et al. Development and validation of a questionnaire to measure asthma control. Eur. Respir. J. 1999; 14 (4): 902–907.

14. Vollmer W.M., Markson L.E., O'Connor E. et al. Association of asthma control with health care utilization and quality of life. Am. J. Respir. Crit. Care Med. 1999; 160 (5, pt 1): 1647–1652.

15. Boulet L.P., Boulet V., Milot J. How should we quantify asthma control? A proposal. Chest 2002; 122 (6): 2217–2223.

16. Bousquet J., Jeffery P.K., Busse W.W. et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 2000; 161 (5): 1720–1745.

17. Ni C.M., Greenstone I.R., Danish A. et al. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Cochrane Database Syst. Rev. 2005; 4: CD005535.

18. Bateman E.D., Jacques L., Goldfrad C. et al. Asthma control can be maintained when fluticasone propionate/salmeterol in a single inhaler is stepped down. J. Allergy Clin. Immunol. 2006; 117 (3): 563–570.

19. Lundback B., Ronmark E., Lindberg A. et al. Control of mild to moderate asthma over 1-year with the combination of salmeterol and fluticasone propionate. Respir. Med. 2006; 100 (1): 2-10.